wintermute000 - absolutely spot on. It was a development funding...

wintermute000 - absolutely spot on.

It was a development funding decision that has let events proceed to the current stage and the sp dampening effect would have been understood, if lamented.

PRR's primary interest is creating and marketing the vaccine and as we know they are actively seeking a better funding arrangement.

The US of A is place where they tip $20m to a waitress for a superlative cuppaccino and we will achieve exposure to a bigger pool of both the philanthropic and hard-nosed, even money-laundering (lol) venture capitalists.

I find it hard to believe they won't (and in short order, whether directly or even through cap raising oportunities that Nasdaq listing will provide) but nonetheless it is good to still have the actual cash that Springtree pours in.